The FDA should create an expedited pathway for clinical tests targeting emerging drug threats, write Dr. Shravani Durbhakula and Jeremy Kourvelas.
November 1, 2026
https://time.com/article/2026/11/01/why-doctors-are-last-to-know-what-s-in-the-drug-supply/